Epidemiology of Injuries Caused by the Practice of Artificial Structure Climbing (EPITRAUMABLOC)

Epidemiology of Injuries Caused by the Practice of Artificial Structure Climbing: Prospective Cohort Study in Réunion Island

This study aims to precisely describe epidemiology of injuries than occur during practice of climbing in artificial structure.

Each participant will complete questionnaires in order to identify injuries. The first questionnaire will be completed at the moment of the inclusion and the second questionnaire will be completed if participant has injuries every 3 months until month 12.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

266

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Pierre, Réunion
        • Climbing structure

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All adult who practices climbing in artificial structure must be included in Reunion Island

Description

Inclusion Criteria:

- person who practices artificial structure climbing

Exclusion Criteria:

  • person who refuses to participate
  • person under tutorship or curatorship
  • person who cannot read and write
  • person who wants to leave Reunion Island within 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
injury relapse or not
Time Frame: at month 3
injury relapse is classified as early relapse if occurs within 2 months after the healing, as late relapse if occurs from 2 months to 12 months after the healing or as very late relapse if occurs after more 12 months.
at month 3
record of exposure to injury
Time Frame: at month 3
Training volume will be recorded by level of practice (leisure practice, club practice and competition practice)
at month 3
location of injury
Time Frame: at month 3
at month 3
laterality of injury
Time Frame: at month 3
at month 3
mechanism of injury
Time Frame: at month 3
it will be identified as a traumatic injury or an overuse. Traumatic injury is due to an acute identified event. An overuse is due to repetitive train injury.
at month 3
circumstance of injury occurence
Time Frame: at month 3
at month 3
diagnosis of injury
Time Frame: at month 3
diagnosis will be claissified according to the OSICS 10 classification
at month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 16, 2021

Primary Completion (Actual)

February 16, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

October 28, 2021

First Submitted That Met QC Criteria

October 28, 2021

First Posted (Actual)

November 8, 2021

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/CHU/27

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sport Injury

Clinical Trials on Questionnaire

Subscribe